Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've typed 'semaglutide dilution calculator' into a search engine, the most useful thing this page can do is explain why that search is a red flag — and what licensed semaglutide in the UK actually looks like. Licensed semaglutide for weight management comes pre-filled, pre-dosed, and ready to inject; there is no mixing, no dilution, and no calculator involved. Dilution calculators exist for compounded or 'research-grade' semaglutide — substances sold outside the licensed medicines supply chain that the MHRA has specifically warned the public about. This page sets the record straight.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception the dilution-calculator search is built on. Compounded semaglutide (sold as a powder or liquid vial, often described as 'research peptide') does require the user to reconstitute it with bacteriostatic water and calculate a precise dose in millilitres. That process is genuinely complex, and a semaglutide mixing calculator or a bacteriostatic water calculator appears to make it manageable. The problem is not the maths. The problem is the substance itself.
Licensed semaglutide for weight management in the UK (sold as Wegovy) comes pre-filled in a pen. Each pen contains a fixed, pre-set dose, calibrated by the manufacturer and verified by the MHRA. You dial to the correct marking, inject, and you are done. There is nothing to mix. There is nothing to dilute. A calculator of the kind people are searching for has no role in a legitimate treatment pathway.
The fact that dilution calculators exist at all reflects how widely unlicensed semaglutide products circulate online, not how the medicine actually works when supplied through the licensed UK supply chain. If a source is telling you that you need to calculate a dilution ratio before injecting semaglutide, that is a signal about the source, not a gap in the product's instructions.
The MHRA has been direct. Its public guidance (published via the Drug Safety Update and accompanying public warnings) makes clear that GLP-1 medicines are not assessed for quick or cosmetic weight loss, and that purchasing these medicines without a prescription from unverified sellers is unsafe. Enforcement action through 2025 resulted in the seizure of roughly 20 million doses of illegally traded weight-loss medicines (an estimated £45 million street value), and the MHRA confirmed the first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided in Northampton in October 2025.
Fake pens have contained insulin, causing serious hypoglycaemic episodes in people who had no diabetes diagnosis and no clinical supervision. Compounded vials present a different but related risk: the potency is unverified, sterility cannot be guaranteed, and the person injecting is doing so without any prescriber oversight. A dilution calculator tells you nothing about whether the powder in the vial is what the seller claims it is, or what strength it actually is.
If you have come across an online semaglutide calculator or a peptide calculator for semaglutide, the safest thing to do is report the seller at the MHRA's Yellow Card scheme, which handles suspect sellers alongside adverse reaction reports.
Wegovy is licensed in the UK for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. The licensed maintenance pathway begins at 0.25 mg once weekly and titrates upward (through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg) with each step guided by the prescriber, typically at four-week intervals. Since January 2026 a 7.2 mg maintenance dose has also been approved, and in April 2026 the MHRA approved a dedicated single-dose 7.2 mg pen for adults with obesity. You can read more about how semaglutide works and what the evidence shows.
Every dose change in a legitimate pathway happens because a clinician has reviewed your response and decided it is appropriate, not because you recalculated a ratio. The pen in the fridge door handles the measurement, your prescriber handles the decision. That division of responsibility is precisely what makes licensed treatment safe.
For cost context, what Wegovy costs privately in the UK depends on dose and provider, but any legitimate price includes a prescription and clinical assessment. A Wegovy dose guide can help you understand the schedule, though specific dose changes always rest with the prescriber.
If you are wondering whether licensed semaglutide is right for you, the place to start is a clinical assessment, not a calculator. Our prescribers at nume review every consultation the same day (a named clinician reads your answers, not automated software) and, if treatment is clinically suitable, your prescription is dispatched the same day for free next-working-day delivery. Start your free consultation to find out whether you are eligible.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.